Evidence map›Paper›PMID 32635932›Full record

ArticleJournal of neuroinflammation2020

Correction to: Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway.

Kun Hou, Guichen Li, Jinchuan Zhao, Baofeng Xu, Yang Zhang, Jinlu Yu, Kan Xu

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Journal of neuroinflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 56 citations in OpenAlex.

  1. Nanobiotechnologies for stroke treatment.Nanomedicine (London, England) · 2025
    Review
  2. Exosomes for angiogenesis induction in ischemic disorders.Journal of cellular and molecular medicine · 2023
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kun HouDepartment of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021, P.R. China.
Guichen LiDepartment of Neurology, The First Hospital of Jilin University, Changchun, 130021, P.R. China.
Jinchuan ZhaoDepartment of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021, P.R. China.
Baofeng XuDepartment of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021, P.R. China.
Yang ZhangDepartment of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021, P.R. China.
Jinlu YuDepartment of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021, P.R. China. jlyu@jlu.edu.cn.
Kan XuDepartment of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021, P.R. China. xu_xukan@126.com.
First Hospital of Jilin University · CNJilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Identifiers

PMID32635932
PMCPMC7341601
OpenAlexW3008139267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.